|
1
|
Farasat S, Yu SS, Neel VA, Nehal KS,
Lardaro T, Mihm MC, Byrd DR, Balch CM, Califano JA, Chuang AY, et
al: A new American Joint Committee on Cancer staging system for
cutaneous squamous cell carcinoma: Creation and rationale for
inclusion of tumor (T) characteristics. J Am Acad Dermatol.
64:1051–1059. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kwon S, Dong ZM and Wu PC: Sentinel lymph
node biopsy for high-risk cutaneous squamous cell carcinoma:
Clinical experience and review of literature. World J Surg Oncol.
9:802011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shimeld SM, Degnan B and Luke GN:
Evolutionary genomics of the Fox genes: Origin of gene families and
the ancestry of gene clusters. Genomics. 95:256–260. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang W, Fan H, Qian C, Ding J, Wang Q and
Pang X: Prognostic value of high FoxC2 expression in resectable
non-small cell lung cancer, alone or in combination with E-cadherin
expression. BMC Cancer. 16:162016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Werden SJ, Sphyris N, Sarkar TR, Paranjape
AN, LaBaff AM, Taube JH, Hollier BG, Ramirez-Peña EQ, Soundararajan
R, den Hollander P, et al: Phosphorylation of serine 367 of FOXC2
by p38 regulates ZEB1 and breast cancermetastasis, without
impacting primary tumor growth. Oncogene. 35:5977–5988. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lai XF, Shen CX, Wen Z, Qian YH, Yu CS,
Wang JQ, Zhong PN and Wang HL: PinX1 regulation of telomerase
activity and apoptosis in nasopharyngeal carcinoma cells. J Exp
Clin Cancer Res. 31:122012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sobecki M, Mrouj K, Camasses A, Parisis N,
Nicolas E, Llères D, Gerbe F, Prieto S, Krasinska L, David A, et
al: The cell proliferation antigen Ki-67 organises heterochromatin.
eLife. 5:e137222016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dong M, Wei H, Hou JM, Gao S, Yang DZ, Lin
ZH, Jia Y, Ren XP and Gao MH: Possible prognostic significance of
p53, cyclin D1 and Ki-67 in the second primary malignancy of
patients with double primary malignancies. Int J Clin Exp Pathol.
7:3975–3983. 2014.PubMed/NCBI
|
|
9
|
Sano H, Leboeuf JP, Novitskiy SV, Seo S,
Zaja-Milatovic S, Dikov MM and Kume T: The Foxc2 transcription
factor regulates tumor angiogenesis. Biochem Biophys Res Commun.
392:201–206. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sasahira T, Ueda N, Yamamoto K, Kurihara
M, Matsushima S, Bhawal UK, Kirita T and Kuniyasu H: Prox1 and
FOXC2 act as regulators of lymphangiogenesis and angiogenesis in
oral squamous cell carcinoma. PLoS One. 9:e925342014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li D, Yan D, Liu W, Li M, Yu J, Li Y, Qu Z
and Ruan Q: Foxc2 overexpression enhances benefit of endothelial
progenitor cells for inhibiting neointimal formation by promoting
CXCR4-dependent homing. J Vasc Surg. 53:1668–1678. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hollier BG, Tinnirello AA, Werden SJ,
Evans KW, Taube JH, Sarkar TR, Sphyris N, Shariati M, Kumar SV,
Battula VL, et al: FOXC2 expression links epithelial-mesenchymal
transition and stem cell properties in breast cancer. Cancer Res.
73:1981–1992. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nishida N, Mimori K, Yokobori T, Sudo T,
Tanaka F, Shibata K, Ishii H, Doki Y and Mori M: FOXC2 is a novel
prognostic factor in human esophageal squamous cell carcinoma. Ann
Surg Oncol. 18:535–542. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou XZ and Lu KP: The
Pin2/TRF1-interacting protein PinX1 is a potent telomerase
inhibitor. Cell. 107:347–359. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bedir R, Güçer H, Şehitoğlu I, Yurdakul C,
Bağcı P and Üstüner P: The role of p16, p21, p27, p53 and Ki-67
expression in the differential diagnosis of cutaneous squamous cell
carcinomas and keratoacanthomas: An immunohistochemical study.
Balkan Med J. 33:121–127. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shen Y, Xu J, Jin J, Tang H and Liang J:
Cyclin D1 expression in Bowens disease and cutaneous squamous cell
carcinoma. Mol Clin Oncol. 2:545–548. 2014.PubMed/NCBI
|
